Update
EN
/
JP
2025.04.02
Corundum Systems Biology Opens U.S. Office to Expand Presence in North America
2025.03.26
Corundum Systems Biology Supports Expansion of World’s Deepest Multiomic Dataset into Japan
2025.03.26
世界最深のマルチオミクスデータ研究の日本展開へ
2024.09.01
本社移転のご案内
Our Mission
Shaping the Future of Health by Advancing the Science of Complexity
Corundum Systems Biology believes that the next wave of health innovation will emerge from systems-level thinking and data-driven discovery. We support transformative breakthroughs in systems biology by investing in the disruptive ideas, foundational platforms and early-stage ventures that turn complex science into scalable, impact-driven solutions.
Our Vision
A World where Human Biology is Decoded in Real Time - and Used to Keep People Healthier, Longer.
Corundum Systems Biology accelerates human-centered discovery through the convergence of human-driven data, high-throughput technologies and computational intelligence. We aim to pioneer a new era of health solutions that are predictive, preventative, and personalized at scale.
Insight Hub
Comming Soon.
Illuminating the future of humanity
Systems Biology
We believe that the future of human health depends on a more integrated, dynamic understanding of biology—one that reflects the complexity of life itself. Systems biology offers a framework to decode this complexity: not by isolating signals, but by capturing the networks of interaction across genes, proteins, tissues, behaviors, species and environments.

We’re particularly focused on ventures that leverage better data and real-world biological context to advance beyond traditional, reductionist paradigms, toward solutions that are adaptive, data-rich, and clinically impactful from day one. Healthcare should not start when someone is ill; well-being is not one-size-fits-all – we look to systems biology to cause a paradigm shift in how we track, diagnose, prevent and treat health.
Partner
We partner with academic labs, biotech founders, and pharma leaders across health and life sciences. Whether through joint ventures, technical co-development, or strategic capital, our model is built for long-term collaboration and translational impact.
Portfolio
We invest in scientific ventures with the potential to shift paradigms—backing technologies and teams that outpace the sector and set new standards for precision, scalability, and clinical relevance.
Team
Scientists. Strategists. Builders. Investors.
Our team brings together domain expertise across biology, data strategy, and venture building.
With deep roots in academia, industry, and entrepreneurship, we operate as long-term partners
— and active contributors — in each company we back.
Company
Name
Corundum Systems Biology Inc.
Established
April 30, 2020
CEO
Hidehiko Otake
会社名
株式会社コランダム・システム・バイオロジー
設立
2020年4月30日設立
CEO
大竹 秀彦
TOKYO
Address
Hiroo Townhouse 1F, 3-14-24 Hiroo, Shibuya-ku,
Tokyo 150-0012, Japan
住所
〒150-0012 東京都渋谷区広尾3丁目14-24
広尾タウンハウス 1F
BOSTON
Address
One Broadway, 4th Floor, Cambridge, MA 02142, USA
住所
One Broadway 4階, Cambridge, MA 02142 アメリカ合衆国
Contact
For partnerships, investment inquiries,
or to learn more about our approach, contact us using the form below.
A member of our team will respond shortly.